Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Justina X. Caushi(Aeras), Kellie N. Smith(Bloomberg (United States)), Taha Merghoub(Cornell University), Poromendro Burman(Bloomberg (United States)), Julie R. Brahmer(Johns Hopkins University), Bernard J. Park(Memorial Sloan Kettering Cancer Center), Matthew D. Hellmann(AstraZeneca (United States)), Alyza Skaist(Sidney Kimmel Comprehensive Cancer Center), Matthew J. Bott(Memorial Sloan Kettering Cancer Center), Ajay Vaghasia(Sidney Kimmel Comprehensive Cancer Center), Janis M. Taube(Bloomberg (United States)), Arbor G. Dykema(Bloomberg (United States)), Peter B. Illei(Johns Hopkins University), Joshua E. Reuss(Georgetown University), Jarushka Naidoo(Sidney Kimmel Comprehensive Cancer Center), Luis Aparicio(Bloomberg (United States)), Mara Lanis(Bloomberg (United States)), Valsamo Anagnostou(Johns Hopkins University), Begum Choudhury(Bloomberg (United States)), Kristen A. Marrone(Johns Hopkins University), Kenneth W. Kinzler(Johns Hopkins University), Richard L. Blosser(Bloomberg (United States)), Margueritta El Asmar(Bloomberg (United States)), David R. Jones(Memorial Sloan Kettering Cancer Center), Brian J. Mog(Howard Hughes Medical Institute), Ada Tam(Bloomberg (United States)), Sune Justesen, Tricia R. Cottrell(Queen's University), Wenpin Hou(City University of New York), Zineb Belcaid(Erasmus MC), Bert Vogelstein(Johns Hopkins University), Laurene S. Cheung(Bloomberg (United States)), Errol L. Bush(Johns Hopkins University), Zhicheng Ji(Johns Hopkins University), Anuj Gupta(Sidney Kimmel Comprehensive Cancer Center), Jennifer Meyers(Sidney Kimmel Comprehensive Cancer Center), Emily Han-Chung Hsiue(Howard Hughes Medical Institute), Kornel E. Schuebel(Sidney Kimmel Comprehensive Cancer Center), Jamie E. Chaft(Memorial Sloan Kettering Cancer Center), Shibin Zhou(Johns Hopkins University), Jiajia Zhang(Bloomberg (United States)), Boyang Zhang(Johns Hopkins University), Rulin Wang(Sidney Kimmel Comprehensive Cancer Center), Jinny S. Ha(Sidney Kimmel Comprehensive Cancer Center), Malcolm V. Brock(Johns Hopkins University), Sampriti Thapa(Bloomberg (United States)), Haidan Guo(Bloomberg (United States)), Dipika Singh(Bloomberg (United States)), Hok Yee Chan(Johns Hopkins University), Victor E. Velculescu(Johns Hopkins University), Sarah J. Wheelan(Sidney Kimmel Comprehensive Cancer Center)
Cited by 546
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k